Greater Flexibility in Dosing Decisions Another commonly cited reason is the desire for flexibility
"The revelation about GLP-1 medication is that it really works against all major substances, and it works uniformly, not because it acts against alcohol or opioids or nicotine specifically, but because it is likely acting against the craving itself
The article explains that these medications act in the hypothalamus, pancreas and gastrointestinal tract, so decisions have to account for renal function, cardiovascular history, diabetes status and prior medication responses
GLP-1 receptors the docking points where GLP-1 attaches and delivers its message are found not just in the pancreas, but also in specific regions of the brain that control hunger, fullness, and food cravings
Is it digestive ease or systemic protection
The reduced form (GSH) is the predominant one, accounting for more than 98% of total glutathione